31 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Pneumocystis pneumonia (PCP ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Pneumocystis pneumonia (PCP ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... Mechanism of Action #Asthma ... Medications #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
Asthma Maintenance ... nonpharmacologic management ... Stepwise #Therapy #Management ... #Pharmacology # ... Pulmonary
Biologic therapy for eosinophilic asthma 
• Mepolizumab (Nucala) 
  • Anti-lL-5, 100 mg SQ q4
for eosinophilic asthma ... #eosinophilic #asthma ... #Medications #pharmacology ... #pulmonary #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
Chest Pain Diagnosis and Management Algorithm
STEMI:
 - Hx: Pressure like CP, Radiation to arm/jaw, CAD risk
Diagnosis and Management ... Limb ischemia Pulmonary ... Dyspnea, H/O COPD, asthma ... , CF, PCP #ChestPain ... #Diagnosis #Management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology